Entellus Medical Inc (ENTL.OQ)
23 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|59||2016||Non-Executive Chairman of the Board|
|55||2015||President, Chief Executive Officer, Director|
|49||2016||Chief Financial Officer, Corporate Secretary|
|43||2017||Chief Operating Officer|
|46||2017||Chief Compliance Officer, Vice President, General Counsel|
- BRIEF-Sand Grove Capital Reports 5.18 Pct Stake In Entellus Medical
- BRIEF-Discovery Group I LLC Says Dissolves Stake In Entellus Medical As Of December 7
- Stryker beefs up ENT business with $662 million Entellus buy
- UPDATE 1-Stryker beefs up ENT business with $662 mln Entellus buy
- BRIEF-Entellus Medical Says Deal May Require Co To Pay Stryker A Termination Fee Of $20.5 Mln